Milton Werner, based in Boston, MA, US, is currently a Founder, President & CEO at Inhibikase Therapeutics, bringing experience from previous roles at Celtaxsys, Inc. and Rockefeller University. Milton Werner holds a 1985 - 1991 PhD in Chemistry, Biochemistry, Biophysics @ University of California, Berkeley. With a robust skill set that includes Drug Discovery, Molecular Biology, Immunology, Lifesciences, Strategy and more, Milton Werner contributes valuable insights to the industry. Milton Werner has 1 email and 1 mobile phone number on RocketReach.